Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $265207.0.

  • Cryo Cell International's Cash & Equivalents rose 3432.49% to $265207.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $265207.0, marking a year-over-year increase of 3432.49%. This contributed to the annual value of $560960.0 for FY2024, which is 3814.47% up from last year.
  • According to the latest figures from Q3 2025, Cryo Cell International's Cash & Equivalents is $265207.0, which was up 3432.49% from $137491.0 recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's Cash & Equivalents peaked at $11.3 million during Q1 2021, and registered a low of $137491.0 during Q2 2025.
  • In the last 5 years, Cryo Cell International's Cash & Equivalents had a median value of $696296.0 in 2022 and averaged $2.6 million.
  • As far as peak fluctuations go, Cryo Cell International's Cash & Equivalents crashed by 9157.34% in 2022, and later skyrocketed by 3814.47% in 2024.
  • Over the past 5 years, Cryo Cell International's Cash & Equivalents (Quarter) stood at $8.3 million in 2021, then plummeted by 91.57% to $696296.0 in 2022, then tumbled by 41.68% to $406067.0 in 2023, then soared by 38.14% to $560960.0 in 2024, then tumbled by 52.72% to $265207.0 in 2025.
  • Its last three reported values are $265207.0 in Q3 2025, $137491.0 for Q2 2025, and $223122.0 during Q1 2025.